For people with prediabetes who receive treatment for coronary artery disease (CAD), the risk for adverse cardiovascular outcomes may not differ from that of persons with normal glucose levels and is substantially lower than for those with type 2 diabetes, new research suggests.
Results from the prospective, observational Innovation to Reduce Cardiovascular Complications of Diabetes at the Intersection Study (ARTEMIS) were published online May 10 in Diabetes Care.
Diabetes Care. Published online May 10, 2019. Abstract
